On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/16/22
- ZoomInfo sees 4% sequential growth in Q4, possible 4%-5% per quarter in 2023
- 11/16/22
- ZoomInfo Technologies trading resumes
- 11/16/22
- ZoomInfo Technologies trading halted, volatility trading pause
- 11/16/22
- ZoomInfo down 15% following conference presentation
- 01/03/23
- Vera Therapeutics shares fall 67% despite ORIGIN trial meeting primary endpoint
- 01/03/23
- Vera Therapeutics announces ORIGIN clinical trial met primary endpoint
- 11/17/22
- Vera Therapeutics to host KOL webinar on targeting the source of IgAN
- 11/09/22
- Vera Therapeutics expects cash to fund oeprations into 2Q24
- 12/08/22
- Veeva director sells $1.64M in common stock
- 12/02/22
- Veeva falls -7.3%
- 11/01/22
- Veeva, Merck establish ten-year strategic partnership agreement
- 10/04/22
- Veeva announces over 350 companies using Veeva Vault RIM Suite applications
- $198.85 /
+9.375 (+4.95%) - 10/25/22
- UniFirst increases quarterly common stock dividend to 31c per share
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 11/28/22
- Texas Instruments announces expansion of its portfolio
- 10/25/22
- Texas Instruments falls 5% to $154.39 after Q4 guidance misses estimates
- 10/25/22
- Texas Instruments: Experienced expected weakness in personal electronics in Q3
- 12/06/22
- TSMC to triple U.S. chip investment to $40B
- 11/14/22
- TSMC jumps 7% to $77.91 after Berkshire Hathaway disclosed added stake
- 10/26/22
- Synopsys, TSMC partner over multi-die design solutions
- 01/04/23
- Toyota Motor North America reports year-end 2022 U.S. sales 2,108,458 vehicles
- 12/27/22
- Toyota reports November worldwide sales rose 2.9% to 796,484 units
- 12/15/22
- Toyota, Oncor partner on EV charging ecosystem
- 01/04/23
- Theratechnologies focused on achieving positive EBITDA in the near-term
- 01/04/23
- Theratechnologies forms committee for Protocol Amendment for TH1902 trial
- 01/04/23
- Theratechnologies CEO says positioned 'product portfolio for commercial success'
- 12/01/22
- Theratechnologies trading resumes
- 12/22/22
- Target recalls roughly 204,000 children's weighted blankets after two deaths
- 11/25/22
- Target announces Cyber Monday sales event from Nov. 27-28
- 11/17/22
- Target announces largest Black Friday week sale ever from Nov. 20-26
- 11/16/22
- Target falls -15.8%
- 01/03/23
- SGH spikes almost 9% after reporting Q1 results that beat expectations
- 11/16/22
- SGH's Penguing Computing to acquire software assets from Colorado Code Craft
- 09/14/22
- Cree LED, Tomar Electronics enter settlement, limited license agreement
- 07/28/22
- SGH CEO buys $181K in common stock stock
- 12/12/22
- Boston Beer's TeaPot launches merchandise collaboration with Peace Collective
- 07/21/22
- Boston Beer drops 10% to $303.40 after lowering FY22 EPS guidance
- 01/04/23
- Visteon, Qualcomm collaborate on development of digital cockpit
- 11/02/22
- Qualcomm falls 7% to $104.90 after Q1 guidance misses estimates
- 11/02/22
- Qualcomm sees low-double digits handset volume declines for 2022
- 10/25/22
- Cognizant expands collaboration with Qualcomm
- 12/29/22
- Pfizer discloses 5.38M share stake in Oric Pharmaceuticals
- 12/29/22
- Pfizer announces topline results from Phase 3 study of fidanacogene elaparvovec
- 12/28/22
- Pfizer announces FDA acceptance of BLA for MenABCWY in adolescents
- 12/26/22
- Fly Intel: Top five weekend stock stories
- 11/01/22
- Fox Corp.: Special Committee has not made any determination on News Corp.
- 10/14/22
- Fox Corp. forms committee to begin exploring potential News Corp. combination
- 12/12/22
- News Corp. appoints Emma Tucker as Editor-in-Chief of The Wall Street Journal
- 12/06/22
- Fox Corp. provides update on potential News Corp. transaction
- 12/05/22
- News Corp. special committee to explore combination with Fox Corp.
- 11/08/22
- News Corp. says Special Committee has not decided on pursuit of Fox deal
- 01/03/23
- Foxconn, Nvidia partner to build automated electric vehicles
- 12/14/22
- IonQ hires Rima Alameddine as Chief Revenue Officer
- 12/07/22
- KULR Technology expands KULR VIBE offering with AI server platform
- 01/02/23
- Fly Intel: Top five weekend stock stories
- 12/30/22
- Micron slides 2% to $49.60 in pre-market after Argus downgrade to Hold
- 12/21/22
- Micron suspends share buybacks
- 12/21/22
- Micron slips about 1% to $50.70 after Q1 earnings miss and guidance
- $229.06 /
-10.67 (-4.45%) - 12/28/22
- Third Activision Blizzard video game unit seeks union
- 12/18/22
- Fly Intel: Top five weekend stock stories
- 12/16/22
- ReNew Energy Global signs 150 MW agreement with Microsoft
- 12/15/22
- Microsoft names Melanie Nakagawa as new Chief Sustainability Officer
- 12/01/22
- Marvell falls 7% to $42.29 after Q3 results, Q4 guidance miss estimates
- 12/01/22
- Marvell reports Q3 adjusted gross margin 64%
- 11/30/22
- Marvell extends collaboration with Nokia
- 10/03/22
- Marvell CEO Carl Hull to switch roles, William Martin to succeed
- $125.17 /
+2.675 (+2.18%) - 12/20/22
- 3M to exit PMAS manufacturing by 2025
- 11/21/22
- 3M announces reseller agreement with Rad AI
- 11/10/22
- California AG sues DuPont, 3M over 'toxic forever chemicals'
- 10/13/22
- 3M V.A.C. Therapy NPWT achieves medical evidence milestone
- 01/04/23
- Irish Data Protection Commission reports conclusion of inquiries into Meta
- 01/04/23
- Meta to appeal both 'substance' of Irish DPC rulings and fines
- 12/23/22
- Meta to settle Cambridge Analytica scandal case for $725M
- 12/19/22
- EU sends Statement of Objections to Meta over 'abusive practices' in Marketplace
- 11/10/22
- Microchip announces LAN8840, LAN8841 Gigabit Ethernet transceiver devices
- 10/26/22
- Microchip announces PIC32CXMT family of 32-bit microprocessors
- 10/19/22
- Microchip intoduces Arm Cortex - M4F-based PIC MCU family
- 09/19/22
- Microchip announces META-DX2 Ethernet PHY portfolio
- 01/04/23
- Mobileye in pact with Wistron NeWeb for software-defined imaging radars
- 10/31/22
- Mobileye CEO buys $10M in common stock
- 10/27/22
- Intel reports Q3 Mobileye revenue $450M
JEF Jefferies Financial Group - $38.70 /
+4.485 (+13.11%) - 12/02/22
- Ebix engages Jefferies as exclusive investment bank
- 11/14/22
- Berkshire Hathaway adds TSMC, exits STORE Capital in Q3
- 11/01/22
- Jefferies Financial Group completes merger with Jefferies Group LLC
- 09/28/22
- Jefferies Financial Group 'increases buyback authorization back to $250M'
- 01/03/23
- Intel announces 13th Gen Core mobile processors plus N-series at CES
- 12/29/22
- Check Point expands collaboration with Intel for anti-ransomware capabilities
- 11/29/22
- Synopsys appoints Shelagh Glaser as CFO
- 12/14/22
- Robinhood raising interest rates for Gold members to 4%
- 12/07/22
- Robinhood reports November MAUs 12.5M
- 12/06/22
- Robinhood CEO says regulators should scrutinize offshore crypto companies
- 12/06/22
- Robinhood opens waitlist for 'Robinhood Retirement' product
- $11.08 /
+1.135 (+11.41%) - 01/04/23
- Hayward rises 9.6%
- 11/01/22
- Hayward rises 13.2%
- 01/04/23
- General Motors reports Q4 U.S. sales up 41% to 623,261 units
- 12/20/22
- Cruise's driverless robotaxis are taking passengers in Phoenix and Austin
- 12/16/22
- NHTSA opens probe into GM's Cruise autonomous driving system
- 12/15/22
- EU passenger car registrations up 16.3% in November
- 01/04/23
- Geron up 48% in pre-market at $3.54 after Phase 3 trial data for imetelstat
- 01/04/23
- Geron reports 'positive' results from IMerge Phase 3 trial of imetelstat
- 08/22/22
- Geron doses first patient in IMproveMF phase 1 study
- 01/04/23
- GE HealthCare completes spin-off from GE, starts trading on Nasdaq
- 12/28/22
- GE HealthCare to replace Vornado Realty Trust in the S&P500 at open on January 4
- 11/30/22
- General Electric board approves separation of GE HealthCare
- $70.18 /
-14.845 (-17.46%) - 01/04/23
- General Electric falls -19.3%
- 01/04/23
- General Electric falls -21.0%
- 01/04/23
- General Electric falls -20.0%
- 11/04/22
- Fox Corp. 'pleased' with 'fair and favorable outcome' of Flutter arbitration
- 11/03/22
- Fox Corp. partners with FreeWheel for OneFOX inventory
- 01/03/23
- Deciphera announces results from ctDNA analysis from Intrigue Phase 3 trial
- 09/11/22
- Deciphera presents updated Phase 1/2 Data for vimseltinib in TGCT
- 09/10/22
- Deciphera presnts initial Phase 1 single agent dose escalation data for DCC-3116
- 08/10/22
- Deciphera announces publication of INTRIGUE study results in journal
- 01/04/23
- Salesforce up 4% to $139.85 after announcing restructuring
- 01/04/23
- Salesforce announces restructuring, 10% workforce reduction
- 12/08/22
- Salesforce CEO: Planning for CRM to be second largest software company
- 12/06/22
- Sprout, Salesforce deepen partnership with addition of Tableau
- $103.98 /
+12.025 (+13.08%) - 12/29/22
- Alibaba names new CTO as CEO steps in interim cloud head
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 11/17/22
- Tims China announces partnership with Alibaba's Freshippo
- 12/20/22
- EU opens antitrust probe into Broadcom's proposed $61B VMware bid
- 12/01/22
- AMD, Viettel collaborate on 5G mobile network expansion
- 11/23/22
- Third quarter CPU shipments down 18.6% compared to Q321, JPR says
- 11/17/22
- AMD, Analog Devices resolve all ongoing patent litigations
- $26.15 /
+3.125 (+13.57%) - 11/23/22
- RocketFuel Blockchain announces launch of loyalty token $Rpay
- 11/21/22
- ACI Worldwide, NTT Data to partner to advance Europe and Latin America market
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 11/08/22
- ACI Worldwide names Thomas Warsop interim CEO
- 07/10/22 Goldman Sachs
- News Corp. downgraded to Buy from Conviction Buy at Goldman Sachs
- 10/17/22 Morgan Stanley
- Morgan Stanley says Fox-News combo would balance more scale with more complexity
- 10/17/22 Loop Capital
- News Corp. downgraded to Hold from Buy at Loop Capital
- 10/17/22 Credit Suisse
- Fox Corp. downgraded to Neutral from Outperform at Credit Suisse
- 07/28/22 Macquarie
- News Corp. downgraded to Neutral at Macquarie ahead of expected 'soft' report
- $125.17 /
+2.675 (+2.18%) - 12/09/22 Citi
- 3M price target raised to $126 from $117 at Citi
- 11/16/22
- 3M followers suggest 'company might be ripe for activist,' says Gordon Haskett
- 10/26/22 Deutsche Bank
- 3M price target raised to $127 from $126 at Deutsche Bank
- 10/26/22 Mizuho
- 3M price target lowered to $130 from $140 at Mizuho
- 11/01/22 Nomura
- Sumitomo Mitsui resumed with a Buy at Nomura
- 06/23/22 BofA
- Sumitomo Mitsui upgraded to Buy from Neutral at BofA
- 04/27/22 Goldman Sachs
- Sumitomo Mitsui initiated with a Buy at Goldman Sachs
- 04/11/22 BofA
- Sumitomo Mitsui downgraded to Neutral from Buy at BofA
JEF Jefferies Financial Group - $38.70 /
+4.485 (+13.11%) - 12/21/22 Keefe Bruyette
- Jefferies downgraded to Market Perform from Outperform at Keefe Bruyette
- 12/21/22 Keefe Bruyette
- Jefferies Financial Group downgraded to Market Perform from Outperform at Keefe Bruyette
- 09/05/22 Keefe Bruyette
- Jefferies upgraded to Outperform from Market Perform at Keefe Bruyette
- 07/18/22 Morgan Stanley
- Jefferies Financial Group price target lowered to $28 from $32 at Morgan Stanley
- 06/02/22 Wolfe Research
- Fox Corp. assumed at Peer Perform from Outperform at Wolfe Research
- 04/19/22 Rosenblatt
- Fox Corp. initiated with a Neutral at Rosenblatt
- 01/04/23 Macquarie
- Fox Corp. price target lowered to $30 from $32 at Macquarie
- 01/03/23 Wolfe Research
- Fox Corp. downgraded to Underperform from Peer Perform at Wolfe Research
- 01/03/23 Wolfe Research
- Fox Corp. downgraded to Underperform from Peer Perform at Wolfe Research
- 11/02/22 RBC Capital
- Fox Corp. price target lowered to $38 from $46 at RBC Capital
- 12/19/22 Barclays
- Robinhood price target lowered to $9 from $10 at Barclays
- 12/12/22 Citi
- Robinhood downgraded to Neutral from Buy at Citi
- 12/12/22 Mizuho
- Fiserv price target lowered to $135 from $145 at Mizuho
- 12/02/22 Piper Sandler
- Piper calls for 'more aggressive headcount reduction' at Coinbase
- $26.15 /
+3.125 (+13.57%) - 11/03/22 Craig-Hallum
- ACI Worldwide price target lowered to $30 from $38 at Craig-Hallum
- 11/02/22 Needham
- ACI Worldwide downgraded to Hold at Needham with headwinds seen persisting
- 11/02/22 Needham
- ACI Worldwide downgraded to Hold from Buy at Needham
- 11/02/22 BTIG
- ACI Worldwide price target lowered to $31 from $46 at BTIG
- 01/05/23 TD Cowen
- Salesforce price target lowered to $175 from $195 at Cowen
- 01/04/23 Jefferies
- Salesforce restructuring plan 'a step in the right direction,' says Jefferies
- 12/08/22 Baird
- Baird downgrades Salesforce on macro, executive turnover concerns
- 12/08/22 Baird
- Salesforce downgraded to Neutral from Outperform at Baird
- 01/04/23 Edward Jones
- GE HealthCare initiated with a Hold at Edward Jones
- 12/06/22 Oppenheimer
- General Electric upgraded to Outperform from Perform at Oppenheimer
- $70.18 /
-14.845 (-17.46%) - 12/16/22 Barclays
- General Electric price target raised to $96 from $92 at Barclays
- 12/09/22 RBC Capital
- General Electric price target raised to $98 from $93 at RBC Capital
- 12/09/22 Citi
- General Electric price target raised to $100 from $87 at Citi
- 12/08/22 Oppenheimer
- Oppenheimer backs Outperform on GE amid weakness
- 01/05/23 Mizuho
- Meta Platforms price target raised to $170 from $160 at Mizuho
- 01/04/23 New Street
- New Street starts Meta Platforms with a Buy, thinks ad revenue can outperform
- 01/03/23 New Street
- Meta Platforms initiated with a Buy at New Street
- 12/16/22 JPMorgan
- Meta Platforms upgraded to Overweight from Neutral at JPMorgan
- 11/18/22 Wedbush
- GM's Investor Day event 'impressive,' says Wedbush
- 11/10/22 Wolfe Research
- General Motors downgraded to Peer Perform from Outperform at Wolfe Research
- 10/26/22 Deutsche Bank
- General Motors price target lowered to $35 from $36 at Deutsche Bank
- 10/26/22 JPMorgan
- General Motors price target raised to $59 from $58 at JPMorgan
- 10/13/22 Citi
- Toyota downgraded to Neutral at Citi on lower earnings outlook
- 10/13/22 Citi
- Toyota downgraded to Neutral from Buy at Citi
- 10/06/22 UBS
- Toyota downgraded to Neutral at UBS on lower profit forecasts
- 10/06/22 UBS
- Toyota downgraded to Neutral from Buy at UBS
- 01/02/23 Rosenblatt
- Rosenblatt reveals 15 best stock ideas for 2023
- 12/30/22 Argus
- Argus cuts Micron to Hold, sees potential operating losses over coming quarters
- 12/30/22 Oppenheimer
- Oppenheimer remain buyers of Enovix after CEO announcement
- 12/30/22 Argus
- Micron downgraded to Hold from Buy at Argus
- $103.98 /
+12.025 (+13.08%) - 11/18/22 Benchmark
- Alibaba price target lowered to $180 from $206 at Benchmark
- 11/18/22 UBS
- Alibaba price target lowered to $135 from $140 at UBS
- 11/18/22 Truist
- Alibaba price target lowered to $120 from $125 at Truist
- 11/18/22 Baird
- Alibaba price target lowered to $120 from $140 at Baird
- 12/15/22 Morgan Stanley
- AMD named 'Top Pick' in Semiconductors at Morgan Stanley
- 11/15/22 Credit Suisse
- Intel assumed with a Neutral at Credit Suisse
- 11/15/22 Credit Suisse
- AMD assumed with an Outperform at Credit Suisse
- 12/13/22 Northland
- Northland starts FormFactor at Outperform with $33 price target
- 12/01/22 New Street
- Mobileye initiated with a Buy at New Street
- 11/22/22 Mizuho
- Intel resumed with a Neutral at Mizuho
- 11/21/22 Morgan Stanley
- Mobileye initiated with an Equal Weight at Morgan Stanley
- 12/02/22 Craig-Hallum
- Marvell price target lowered to $63 from $90 at Craig-Hallum
- 12/02/22 BMO Capital
- Marvell price target lowered to $65 from $75 at BMO Capital
- 12/02/22 Jefferies
- Jefferies would 'buy the confession' after Marvell guidance miss
- 11/29/22 Stifel
- Microchip price target raised to $80 from $77 at Stifel
- 11/15/22 Credit Suisse
- Microchip initiated with a Neutral at Credit Suisse
- 11/04/22 UBS
- Microchip price target lowered to $90 from $100 at UBS
- 11/03/22 Piper Sandler
- Microchip price target lowered to $80 from $100 at Piper Sandler
- 12/19/22 Needham
- Nvidia price target raised to $230 from $200 at Needham
- 12/15/22 HSBC
- Nvidia initiated with a Reduce at HSBC
- 12/14/22 Deutsche Bank
- Nvidia price target raised to $170 from $150 at Deutsche Bank
- 12/20/22 JPMorgan
- Qualcomm price target lowered to $160 from $185 at JPMorgan
- 12/12/22 Wells Fargo
- Wells Fargo downgrades Qualcomm to Underweight with $105 price target
- 12/12/22 Wells Fargo
- Qualcomm downgraded to Underweight from Equal Weight at Wells Fargo
- 11/15/22 Credit Suisse
- Qualcomm initiated with an Outperform at Credit Suisse
- 12/14/22 Deutsche Bank
- Texas Instruments price target raised to $158 from $155 at Deutsche Bank
- 11/15/22 Credit Suisse
- Texas Instruments assumed with Neutral from Outperform at Credit Suisse
- 11/01/22 Craig-Hallum
- Lattice Semiconductor price target lowered to $50 from $58 at Craig-Hallum
- 10/26/22 Susquehanna
- Texas Instruments price target lowered to $195 from $215 at Susquehanna
- 11/18/22 Erste Group
- TSMC upgraded to Buy from Hold at Erste Group
- 10/17/22 Northland
- Teradyne price target lowered to $74 from $85 at Northland
- 10/13/22 Goldman Sachs
- TSMC downgraded to Buy from Conviction Buy at Goldman Sachs
- $229.06 /
-10.67 (-4.45%) - 01/04/23 DA Davidson
- DA Davidson starts Microsoft at Buy, believes ChatGPT can unseat Google Search
- 01/04/23 DA Davidson
- Microsoft initiated with a Buy at DA Davidson
- 01/04/23 UBS
- Microsoft downgraded to Neutral from Buy at UBS
- 12/22/22 Needham
- Netflix 2023 estimates cut at Needham
- 01/04/23 Wells Fargo
- Wells Fargo downgrades Target to Equal Weight, lowers price target to $142
- 01/04/23 Wells Fargo
- Target downgraded to Equal Weight from Overweight at Wells Fargo
- 12/21/22
- Gordon Haskett downgrades Target on 'meaningfully eroded' traffic
- 12/21/22
- Target downgraded to Hold from Buy at Gordon Haskett
- 01/04/23 Jefferies
- Boston Beer downgraded to Underperform from Hold at Jefferies
- 12/06/22 Deutsche Bank
- Boston Beer downgraded to Sell from Hold at Deutsche Bank
- 11/07/22 Morgan Stanley
- Boston Beer initiated with an Underweight at Morgan Stanley
- 10/24/22 UBS
- Boston Beer price target raised to $412 from $312 at UBS
- 01/04/23 Barclays
- Barclays upgrades Veeva to Overweight as defensive pick
- 01/04/23 Barclays
- Veeva upgraded to Overweight from Equal Weight at Barclays
- 12/06/22 TD Cowen
- Veeva initiated with a Market Perform at Cowen
- 12/05/22 KeyBanc
- Veeva price target lowered to $210 from $220 at KeyBanc
- 01/04/23 BofA
- BioMarin price target raised to $200, added to 'US 1 List' at BofA
- 01/04/23 BofA
- Pfizer downgraded to Neutral at BofA on COVID-19 uncertainty
- 01/04/23 BofA
- Pfizer downgraded to Neutral from Buy at BofA
- 01/03/23 Needham
- Vaxcyte named as Top Pick, added to Conviction list at Needham
- 01/04/23 Wedbush
- Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
- 10/28/22 Wedbush
- Wedbush starts Geron with Outperform, $5 price target
- 10/27/22 Wedbush
- Geron initiated with an Outperform at Wedbush
- 07/28/22 B. Riley
- Geron resumed with a Buy at B. Riley
- $11.08 /
+1.135 (+11.41%) - 01/04/23 Jefferies
- Jefferies upgrades Hayward to Buy after 64% selloff in 2022
- 01/03/23 Jefferies
- Hayward upgraded to Buy from Hold at Jefferies
- 12/12/22 Stifel
- Hayward initiated with a Buy at Stifel
- 10/18/22 BofA
- Hayward downgraded to Underperform at BofA
- 01/04/23 Jefferies
- Vera Therapeutics downgraded to Hold from Buy at Jefferies
- 01/04/23 Wedbush
- Wedbush downgrades Vera Therapeutics to Neutral, lowers price target to $8
- 01/04/23 Wedbush
- Vera Therapeutics downgraded to Neutral from Outperform at Wedbush
- 01/04/23 H.C. Wainwright
- Vera Therapeutics price target lowered to $15 from $36 at H.C. Wainwright
- 12/16/22 Mizuho
- Mobileye price target raised to $40 from $35 at Mizuho
- 12/13/22 JPMorgan
- Mobileye initiated with an Overweight at JPMorgan
- 12/08/22 Baird
- Mobileye price target raised to $39 from $36 at Baird
- 12/05/22 Tigress Financial
- Mobileye initiated with a Buy at Tigress Financial
- 01/04/23 BofA
- ZoomInfo downgraded to Neutral from Buy at BofA
- 12/08/22 Mizuho
- ZoomInfo price target lowered to $45 from $50 at Mizuho
- 12/07/22 Canaccord
- ZoomInfo price target lowered to $43 from $48 at Canaccord
- 11/23/22 RBC Capital
- ZoomInfo price target lowered to $36 from $50 at RBC Capital
- 02/10/22 Oppenheimer
- Perion Network price target lowered to $30 from $35 at Oppenheimer
- 01/31/22 Stifel
- Perion Network resumed with a Buy at Stifel
- 01/04/23 Needham
- SGH price target raised to $25 from $23 at Needham
- 01/04/23 Deutsche Bank
- SGH price target lowered to $20 from $24 at Deutsche Bank
- 01/04/23 Barclays
- SGH price target raised to $20 from $15 at Barclays
- 10/25/22 Needham
- SGH price target lowered to $23 from $30 at Needham
- $198.85 /
+9.375 (+4.95%) - 05/18/22 Baird
- UniFirst price target lowered to $195 from $213 at Baird
- 04/01/22 JPMorgan
- UniFirst downgraded to sell on missed earnings pattern at JPMorgan
- 04/01/22 JPMorgan
- UniFirst downgraded to Underweight from Neutral at JPMorgan
- 11/30/22 JonesResearch
- Theratechnologies initiated with a Buy at JonesTrading
- 11/17/22 Cantor Fitzgerald
- Theratechnologies initiated with an Overweight at Cantor Fitzgerald
- 07/15/22 National Bank
- Theratechnologies price target lowered to C$3.25 from C$3.75 at National Bank
- 01/04/23 Barclays
- Deciphera price target raised to $9 from $8 at Barclays
- 01/04/23 Guggenheim
- Deciphera upgraded to Buy from Neutral at Guggenheim
- 01/04/23 Guggenheim
- Deciphera upgraded to Buy from Neutral at Guggenheim
- 09/27/22 Stifel
- Deciphera price target raised to $18 from $11 at Stifel
- 11/01/22
- ZoomInfo raises FY22 EPS view to 83c-84c from 78c-80c
- 11/01/22
- ZoomInfo sees Q4 EPS 21c-22c, consensus 21c
- 11/01/22
- ZoomInfo reports Q3 EPS 24c, consensus 20c
- 11/09/22
- Vera Therapeutics reports Q3 EPS (91c), consensus (72c)
- 08/10/22
- Vera Therapeutics reports Q2 EPS (55c) vs (33c) last year
- 12/01/22
- Veeva raises 2023 non-GAAP EPS view to $4.19 from $4.16, consensus $4.15
- 12/01/22
- Veeva reports Q3 non-GAAP EPS $1.13, consensus $1.07
- 08/31/22
- Veeva sees Q3 EPS $1.07-$1.08, consensus $1.07
- 08/31/22
- Veeva raises 2022 non-GAAP EPS view to $4.17 from $4.16, consensus $4.14
- $198.85 /
+9.375 (+4.95%) - 01/04/23
- UniFirst sees 2023 adjusted EPS $7.10-$7.50, consensus $7.21
- 01/04/23
- UniFirst reports Q1 adjusted EPS $2.21, consensus $1.94
- 10/19/22
- UniFirst sees 2023 adjusted EPS $7.10-$7.50, consensus $7.72
- 10/19/22
- UniFirst reports Q4 adjusted EPS $1.79, consensus $1.73
- 10/25/22
- Texas Instruments sees Q4 EPS $1.83-$2.11, consensus $2.21
- 10/25/22
- Texas Instruments reports Q3 EPS $2.47, consensus $2.39
- 07/26/22
- Texas Instruments sees Q3 EPS $2.23-$2.51, consensus $2.26
- 07/26/22
- Texas Instruments reports Q2 EPS $2.45, consensus $2.12
- 10/13/22
- TSMC sees Q4 revenue $19.9B-$20.7B, consensus $19.76B
- 10/13/22
- TSMC reports Q3 EPS $1.79, consensus $1.41
- 07/14/22
- TSMC sees Q3 revenue $19.8B-$20.6B, consensus $19.21B
- 07/14/22
- TSMC reports Q2 EPS $1.55, consensus $1.47
- 11/01/22
- Toyota sees FY23 EPS 172.28, revenue Y36T
- 11/01/22
- Toyota reports 1H EPS Y85.42 vs. Y109.28 last year
- 08/04/22
- Toyota sees FY23 EPS Y171.95, revenue Y34.5T
- 08/04/22
- Toyota reports Q1 EPS Y53.54 vs. Y64.23 last year
- 01/04/23
- Theratechnologies sees 2023 revenue $90M-$95M, consensus $95.44M
- 01/04/23
- Theratechnologies sees 2022 revenue $80M, consensus $79.38M
- 10/13/22
- Theratechnologies on track for 2022 revenue guidance $79M-$82M, two est. $81.2M
- 10/13/22
- Theratechnologies reports Q3 revenue $20.8M vs. $17.9M last year
- 11/16/22
- Target on track to deliver total sales of well over $100B this year, says COO
- 11/16/22
- Target reports Q3 adjusted EPS $1.54, consensus $2.13
- 11/15/22
- Notable companies reporting before tomorrow's open
- 01/03/23
- SGH sees Q2 adjusted EPS 60c, plus or minus 15c, consensus 57c
- 01/03/23
- SGH reports Q1 adjusted EPS 79c, consensus 57c
- 10/04/22
- SGH sees Q1 adjusted EPS 60c, plus or minus 15c, consensus 76c
- 10/04/22
- SGH reports Q4 adjusted EPS 80c, consensus 65c
- 10/20/22
- Boston Beer narrows FY22 adj EPS view to $7.00 to $10.00 from $6.00-$11.00
- 10/20/22
- Boston Beer reports Q3 EPS $2.21, consensus $3.07
- 07/21/22
- Boston Beer cuts FY22 adjusted EPS view to $6.00-$11.00 from $11.00-$16.00
- 07/21/22
- Boston Beer reports Q2 EPS $4.31, consensus $4.59
- 11/02/22
- Qualcomm sees Q1 adjusted EPS adjusted EPS $2.25-$2.45, consensus $3.42
- 11/02/22
- Qualcomm reports Q4 adjusted EPS $3.13, consensus $3.13
- 07/27/22
- Qualcomm sees Q4 adjusted EPS $3.00-$3.30, consensus $3.23
- 11/01/22
- Pfizer raises FY22 adjusted EPS view to $6.40-$6.50 from $6.30-$6.45
- 11/01/22
- Pfizer reports Q3 adjusted EPS $1.78, consensus $1.39
- 01/04/23
- Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M
- 01/04/23
- Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M
- 11/09/22
- Perion Network reports Q3 EPS 61c, consensus 43c
- 10/06/22
- Perion reports preliminary Q3 revenue $158M, consensus $155.4M
- 11/08/22
- News Corp. reports Q1 adjusted EPS 12c, consensus 15c
- 08/08/22
- News Corp. reports Q4 adjusted EPS 37c, consensus 7c
- 11/16/22
- Nvidia sees Q4 revenue $6B, +/- 2%, consensus $6.09B
- 11/16/22
- Nvidia reports Q3 EPS 58c, consensus 69c
- 11/16/22
- Notable companies reporting after market close
- 08/24/22
- Nvidia down 5% after Q2 report, Q3 guidance
- 12/21/22
- Micron sees Q2 EPS (72c) to (52c), consensus (30c)
- 12/21/22
- Micron reports Q1 EPS (4c), consensus (1c)
- 12/21/22
- Notable companies reporting after market close
- 09/29/22
- Micron sees Q2 revenue range similar to Q1
- $229.06 /
-10.67 (-4.45%) - 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 10/25/22
- Notable companies reporting after market close
- 07/26/22
- Microsoft sees FY23 revenue growth in double digits, consensus $225.98B
- 12/01/22
- Marvell sees Q4 adjusted EPS 46c +/- 5c, consensus 62c
- 12/01/22
- Marvell reports Q3 adjusted EPS 57c, consensus 59c
- 12/01/22
- Notable companies reporting after market close
- 08/25/22
- Marvell sees Q3 adjusted EPS 59c +/- 3c, consensus 60c
- $125.17 /
+2.675 (+2.18%) - 10/25/22
- 3M cuts FY22 adjusted EPS view to $10.10-$10.35 from $10.30-$10.80
- 10/25/22
- 3M reports Q3 adjusted EPS $2.69, consensus $2.60
- 10/24/22
- Notable companies reporting before tomorrow's open
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 10/26/22
- Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
- 10/26/22
- Meta Platforms reports Q3 EPS $1.64, consensus $1.89
- 10/26/22
- Notable companies reporting after market close
- 11/28/22
- Microchip back Q3 EPS view $1.54-$1.56, consensus $1.58
- 11/03/22
- Microchip sees Q3 EPS $1.54-$1.56, consensus $1.45
- 11/03/22
- Microchip reports Q2 EPS $1.46, consensus $1.44
- 11/03/22
- Notable companies reporting after market close
- 12/07/22
- Mobileye sees Q4 revenue $527M-$545M, consensus $483.72M
- 12/07/22
- Mobileye sees FY22 revenue $1.831B-$1.849B, consensus $1.78B
- 12/07/22
- Mobileye reports Q3 EPS (6c), consensus 12c
JEF Jefferies Financial Group - $38.70 /
+4.485 (+13.11%) - 09/28/22
- Jefferies Financial Group reports Q3 adjusted EPS $1.10, consensus 73c
- 12/05/22
- Intel sees down Q1 sales down 5%-7% as 'right starting point for seasonality'
- 10/27/22
- Intel sees Q4 adjusted EPS 20c, consensus 66c
- 10/27/22
- Intel cuts FY22 adjusted EPS view to $1.95 from $2.30
- 10/27/22
- Intel cuts FY revenue view to $63B-$64B from $65B-$68B
- 11/02/22
- Robinhood reports Q3 EPS (20c), consensus (31c)
- 11/02/22
- Notable companies reporting after market close
- 08/03/22
- Notable companies reporting after market close
- 08/02/22
- Robinhood reports Q2 EPS (34c), consensus (37c)
- $11.08 /
+1.135 (+11.41%) - 07/28/22
- Hayward lowers FY22 revenue growth view to (6%)-(2%) from 9%-12%
- 07/28/22
- Hayward reports Q2 EPS 29c, consensus 35c
- 11/17/22
- General Motors narrows FY22 EBIT-adjusted view to $13.5B-$14.5B from $13B-$15B
- 10/25/22
- General Motors backs FY22 adjusted EPS view $6.50-$7.50, consensus $6.79
- 10/25/22
- General Motors reports Q3 adjusted EPS $2.25, consensus $1.88
- 11/03/22
- Geron reports Q3 EPS (10c), consensus (9c)
- 08/11/22
- Geron reports Q2 EPS (7c), consensus (9c)
- $70.18 /
-14.845 (-17.46%) - 10/25/22
- General Electric sees FY22 adjusted EPS $2.40-$2.80, consensus $2.63
- 10/25/22
- General Electric reports Q3 adjusted EPS 35c, consensus 46c
- 11/01/22
- Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14
- 10/31/22
- Notable companies reporting before tomorrow's open
- 08/10/22
- Fox Corp. reports Q4 adjusted EPS 74c, consensus 76c
- 01/03/23
- Deciphera sees FY22 revenue roughly $134M, consensus $132.52M
- 01/03/23
- Deciphera sees Q4 revenue roughly $36M, consensus $34.83M
- 11/03/22
- Deciphera reports Q3 EPS (55c), consensus (58c)
- 08/04/22
- Deciphera reports Q2 EPS (60c), consensus (66c)
- 11/30/22
- Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73
- 11/30/22
- Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34
- 11/30/22
- Salesforce reports Q3 EPS $1.40, consensus $1.21
- 11/30/22
- Notable companies reporting after market close
- $103.98 /
+12.025 (+13.08%) - 11/17/22
- Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64
- 11/16/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Alibaba reports Q1 adjusted EPS $1.75, consensus $1.53
- 11/01/22
- AMD cuts FY22 revenue view to $23.5B +/- $300M from $26.3B +/- $300M
- 11/01/22
- AMD sees Q4 revenue $5.5B +/- $300M, consensus $5.85B
- 11/01/22
- AMD reports Q3 EPS 67c, consensus 68c
- 11/01/22
- Notable companies reporting after market close
- $26.15 /
+3.125 (+13.57%) - 11/02/22
- ACI Worldwide backs FY22 revenue view $1.4B-$1.42B, consensus $1.46B
- 11/02/22
- ACI Worldwide reports Q3 adjusted EPS 11c, consensus 20c
- 09/01/22
- ACI Worldwide lowers FY22 revenue view to $1.4B-$1.42B from $1.415B-$1.435B
- 09/01/22
- ACI Worldwide lowers Q3 revenue view to $306M-$321M from $310M-$325M
|